Blastic plasmacytoid dendritic cell neoplasm (BPDCN) in leukaemic phase without skin lesions: a diagnostic and management challenge

被引:6
|
作者
Murphy, Nicholas [1 ]
Owens, Daniel [2 ]
Hinds, Emily [3 ]
Nelson, Niles [1 ]
机构
[1] Royal Hobart Hosp, Dept Haematol, Hobart, Tas, Australia
[2] Hobart Pathol, Hobart, Tas, Australia
[3] Royal Hobart Hosp, Dept Pathol, Special Diagnost, Hobart, Tas, Australia
关键词
EXPRESSION;
D O I
10.1016/j.pathol.2018.11.016
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:439 / 441
页数:4
相关论文
共 50 条
  • [1] Blastic plasmacytoid dendritic cell neoplasm (BPDCN) - a diagnostic challenge
    Cristian, M.
    Seicaru, L.
    Polimaru, R.
    Baltatescu, G.
    Calin, E.
    Caloian, A.
    Mazilu, L.
    Deacu, S.
    VIRCHOWS ARCHIV, 2024, 485 : S309 - S309
  • [2] Blastic, Plasmacytoid, Dendritic Cell Neoplasm (BPDCN)
    Stranzenbach, R.
    Roppa, M.
    Stadler, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 21 - 21
  • [3] Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations
    Evgenii Shumilov
    Paolo Mazzeo
    Susanne Ghandili
    Axel Künstner
    Sören Weidemann
    Yara Banz
    Philipp Ströbel
    Matthias Pollak
    Lina Kolloch
    Helmut Beltraminelli
    Andrea Kerkhoff
    Jan-Henrik Mikesch
    Christoph Schliemann
    Detlef Haase
    Gerald Wulf
    Myriam Legros
    Georg Lenz
    Laurence Feldmeyer
    Thomas Pabst
    Hanno Witte
    Niklas Gebauer
    Ulrike Bacher
    Annals of Hematology, 2024, 103 : 1587 - 1599
  • [4] Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations
    Shumilov, Evgenii
    Mazzeo, Paolo
    Ghandili, Susanne
    Kuenstner, Axel
    Weidemann, Soeren
    Banz, Yara
    Stroebel, Philipp
    Pollak, Matthias
    Kolloch, Lina
    Beltraminelli, Helmut
    Kerkhoff, Andrea
    Mikesch, Jan-Henrik
    Schliemann, Christoph
    Haase, Detlef
    Wulf, Gerald
    Legros, Myriam
    Lenz, Georg
    Feldmeyer, Laurence
    Pabst, Thomas
    Witte, Hanno
    Gebauer, Niklas
    Bacher, Ulrike
    ANNALS OF HEMATOLOGY, 2024, 103 (05) : 1587 - 1599
  • [5] Blastic plasmacytoid dendritic cell neoplasm (BPDCN): the cutaneous sanctuary
    Pileri, A.
    Delfino, C.
    Grandi, V.
    Agostinelli, C.
    Pileri, S. A.
    Pimpinelli, N.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2012, 147 (06): : 603 - 608
  • [6] Outcomes of CNS involvement in blastic plasmacytoid dendritic cell neoplasm (BPDCN).
    Greenwell, Irl Brian
    Davis, James
    Li, Hong
    Soong, Deborah
    Taylor, Justin
    Lane, Andrew A.
    Rizzieri, David
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Evaluating tagraxofusp for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN)
    Wilson, Nathaniel R.
    Pemmaraju, Naveen
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (04) : 431 - 438
  • [8] Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    Economides, Minas P.
    Rizzieri, David
    Pemmaraju, Naveen
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (06) : 515 - 522
  • [9] Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    Minas P. Economides
    David Rizzieri
    Naveen Pemmaraju
    Current Hematologic Malignancy Reports, 2019, 14 : 515 - 522
  • [10] Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN)
    Alfayez, Mansour
    Konopleva, Marina
    Pemmaraju, Naveen
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (02) : 115 - 123